Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENEW-ALC-1
CTR20255012Phase 3Active
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of brenipatide in alcohol use disorder (AUD), sponsored by Eli Lilly and Company. Started Mar 2026; status: active.
02
Drugs
brenipatide
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on CTR20255012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255012.